Ti3C2Tx MXene nanosheets enhance the tolerance of Torreya grandis to Pb stress.

As a 2D nanomaterial, MXene (Ti3C2Tx) has shown enormous potential for use in fields such as biomedical and environmental pollution. However, the utilization of MXene materials in plants has received little attention thus far. The efficient use of MXene materials in agriculture and forestry is first highlighted in this study. Phenotypic and physiological analyses indicated that MXene application significantly enhanced the tolerance of Torreya grandis to Pb stress by reducing Pb accumulation. Furthermore, we illustrated two independent mechanisms of MXene material in reducing Pb accumulation in T. grandis: 1) MXene converted the available form of Pb into stable forms via its strong Pb adsorption ability, resulting in a decrease of the available form of Pb in soils, and 2) MXene application obviously increased the cell wall pectin content to restrict more Pb in the cell wall by regulating the expression of pectin synthesis/metabolism-related genes (TgPLL2, TgPLL11, TgPG5, TgPG30, TgGAUT3 and TgGAUT12) in T. grandis roots. Overall, this finding provides insight into the application of MXene material in modern agriculture and forestry, which will facilitate the rapid development of nanotechnology in sustainable agriculture and forestry.

A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer.

Objective: To compare the efficacy and safety of hyperthermic intravesical chemotherapy (HIVEC) and intravesical chemotherapy (IVEC) in patients with intermediate and high risk nonmuscle-invasive bladder cancer (NMIBC) after transurethral resection. Methods: We included 560 patients diagnosed with primary or recurrent NMIBC between April 2009 and December 2015 at 1 of 6 tertiary centers. We matched 364 intermediate or high risk cases and divided them into 2 groups: the HIVEC+IVEC group [chemohyperthermia (CHT) composed of 3 consecutive sessions followed by intravesical instillation without hyperthermia] and the IVEC group (intravesical instillation without hyperthermia). The data were recorded in the database. The primary endpoint was 2-year recurrence-free survival (RFS) in all NMIBC patients (n = 364), whereas the secondary endpoints were the assessment of radical cystectomy (RC) and 5-year overall survival (OS). Results: There was a significant difference in the 2-year RFS between the two groups in all patients (n = 364; HIVEC+IVEC: 82.42% vs. IVEC: 74.18%, P = 0.038). Compared with the IVEC group, the HIVEC+IVEC group had a lower incidence of RC (P = 0.0274). However, the 5-year OS was the same between the 2 groups (P = 0.1434). Adverse events (AEs) occurred in 32.7% of all patients, but none of the events was serious (grades 3-4). No difference in the incidence or severity of AEs between each treatment modality was observed. Conclusions: This retrospective study showed that HIVEC+IVEC had a higher 2-year RFS and a lower incidence of RC than IVEC therapy in intermediate and high risk NMIBC patients. Both treatments were well-tolerated in a similar manner.

Evaluation of antiviral activity of compounds isolated from Ranunculus sieboldii and Ranunculus sceleratus.

Nineteen compounds isolated from Ranunculus sieboldii and Ranunculus sceleratus were tested for inhibitory effects on hepatitis B virus (HBV) and Herpes simplex virus type-1 (HSV-1). The results showed that apigenin 4'- O- alpha-rhamnopyranoside, apigenin 7- O- beta-glucopyranosyl-4'- O- alpha-rhamnopyranoside, tricin 7- O- beta-glucopyranoside, tricin, and isoscopoletin possessed inhibitory activity against HBV replication. Protocatechuyl aldehyde exhibited an inhibiting activity on HSV-1 replication. It is therefore suggested that further investigations on these bioactive compounds might be needed to discover and develop new antiviral agents.